COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:
Working… Menu

PreView PHP Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00358345
Recruitment Status : Completed
First Posted : July 31, 2006
Last Update Posted : January 15, 2008
Information provided by:
Notal Vision Inc.

Brief Summary:

The primary objective of this study is to assess the ability of the PreView PHP(study device)to detect newly diagnosed non-treated Choroidal Neovascularization (CNV)lesion associate with advanced Age-related Macular Degeneration (AMD) or Myopia and differentiate them from Intermediate AMD or Geographic Atrophy (GA)or patients with high Myopia with no CNV.

This study secondary is to enhance NotalVision normative database.

Condition or disease
Age Related Macular Degeneration

Detailed Description:
  • The study is prospective, multi-center, comparative study.
  • A clinical trail with FDA approval device (510K).

Layout table for study information
Study Type : Observational
Actual Enrollment : 347 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: PHP Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization
Study Start Date : October 2003
Actual Study Completion Date : September 2007

Resource links provided by the National Library of Medicine

Intermediate AMD
Newly diagnosed CNV

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   50 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
At least 200 subjects with intermediate AMD in at least one (1) eye based on medical record review and/or clinical diagnosis and at least 200 subjects with neovascular AMD in at least one (1) eye.

Inclusion Criteria:

  • Newly diagnosed (up yo 2 months) CNV OR Intermediate AMD
  • Age >50 for AMD subjects
  • Age >18 for Myopic subjects
  • VA 20/160 or better in the study eye
  • Mental and physical ability to performed a PHP test

Exclusion Criteria:

  • Evidence of macular disease other than AMD or high myopia in the study eye.
  • Previous surgical or laser treatment within the macular erea.
  • Concurrent intraocular drug therapy (within 30 days).
  • Present of any significant media opacity that preclude a clear veiw of the macula.
  • Any non macular related ocular surgery performed within 3 months prior to the study.
  • CNV subjects inability to tolerate intravenous fluorscien angiography.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00358345

Layout table for location information
Tel Aviv Sourasky medical center
Tel Aviv, Israel
Sponsors and Collaborators
Notal Vision Ltd.
Layout table for investigator information
Study Director: Ofer Sharon, MD Notal Vision
Layout table for additonal information
Responsible Party: Osnat Ehrman, NotalVision Identifier: NCT00358345    
Other Study ID Numbers: PHP C9
First Posted: July 31, 2006    Key Record Dates
Last Update Posted: January 15, 2008
Last Verified: January 2008
Keywords provided by Notal Vision Inc.:
Additional relevant MeSH terms:
Layout table for MeSH terms
Macular Degeneration
Choroidal Neovascularization
Neovascularization, Pathologic
Retinal Degeneration
Retinal Diseases
Eye Diseases
Pathologic Processes
Choroid Diseases
Uveal Diseases